These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4207732)

  • 41. GENETIC VARIANTS OF ALPHA 1-ANTITRYPSIN.
    LAURELL CB
    Vox Sang; 1965; 10():363-4. PubMed ID: 14332943
    [No Abstract]   [Full Text] [Related]  

  • 42. ELECTROPHORETIC MICROHETEROGENEITY OF SERUM ALPHA-1-ANTITRYPSIN.
    LAURELL CB
    Scand J Clin Lab Invest; 1965; 17():271-4. PubMed ID: 14316471
    [No Abstract]   [Full Text] [Related]  

  • 43. Separation of human alpha-1-antitrypsin from serum albumin by ion-exchange chromatography.
    Bellet H; De Bornier BM
    Clin Chim Acta; 1975 May; 61(1):107-9. PubMed ID: 238762
    [No Abstract]   [Full Text] [Related]  

  • 44. Alpha 1-antitrypsin: a possible tool for diagnosis of cervical cancer.
    Bhattacharyya J; Chaudhuri L
    Biochem Med Metab Biol; 1990 Jun; 43(3):243-5. PubMed ID: 2116815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new, mouse-myeloma immunoglobulin A having specificity for beta-D-(1 yields 6)-linked D-galactopyranosyl residues.
    Manjula BN; Glaudemans CP; Mushinski E; Potter M
    Carbohydr Res; 1975 Mar; 40(1):137-42. PubMed ID: 804990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of biological and immunological methods for determination of serum alpha1-antitrypsin.
    Sugiura M; Akatsuka M; Hirano K; Sawaki S; Saito Y
    Chem Pharm Bull (Tokyo); 1978 Jan; 26(1):220-5. PubMed ID: 416918
    [No Abstract]   [Full Text] [Related]  

  • 47. Binding of alpha 1 antitrypsin (alpha 1 protease inhibitor) to human lymphocytes.
    Bata J; Deviller P; Revillard JP
    Biochem Biophys Res Commun; 1981 Feb; 98(3):709-16. PubMed ID: 6971641
    [No Abstract]   [Full Text] [Related]  

  • 48. Chemical modifications of lysyl and arginyl residues of human plasma alpha1-antitrypsin.
    Busby TF; Gan JC
    Arch Biochem Biophys; 1976 Dec; 177(2):552-60. PubMed ID: 827977
    [No Abstract]   [Full Text] [Related]  

  • 49. A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application.
    O'Brien ME; Murray G; Gogoi D; Yusuf A; McCarthy C; Wormald MR; Casey M; Gabillard-Lefort C; McElvaney NG; Reeves EP
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detailed Structure and Pathophysiological Roles of the IgA-Albumin Complex in Multiple Myeloma.
    Kawata Y; Hirano H; Takahashi R; Miyano Y; Kimura A; Sato N; Morita Y; Kimura H; Fujita K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the serum level of IgA-alpha-1-antitrypsin complex correlate with radiological progression in early rheumatoid arthritis? A 3-year follow-up study.
    Lacki JK; Schochat T; Porawaska W; Mackiewicz SH; Müller W
    Rheumatol Int; 1995; 14(6):227-30. PubMed ID: 7597377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IgA paraprotein inhibition of human neutrophil chemotaxis. Reduced activity following treatment with IgA-specific protease from Neisseria gonorrhoeae.
    Van Epps DE; Plaut A; Bernier GM; Williams RC
    Inflammation; 1980 Jun; 4(2):137-44. PubMed ID: 6771212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protein contents and binding modes of immunoglobulin-amylase complexes.
    Ohtani H; Sakaguchi K; Saito M
    J Clin Pathol; 1982 Apr; 35(4):385-9. PubMed ID: 6176597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macroamylasemia and other immunoglobulin-complexed enzyme disorders.
    Klonoff DC
    West J Med; 1980 Nov; 133(5):392-407. PubMed ID: 6162278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production and characterization of pepsin fragments of human IgA1 to determine domain-specificity of monoclonal anti-IgA antibodies.
    Biewenga J; Faber A; Pronk JC; Haaijman JJ
    Immunology; 1986 Sep; 59(1):153-8. PubMed ID: 3093370
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.
    Monteiro RC; Kubagawa H; Cooper MD
    J Exp Med; 1990 Mar; 171(3):597-613. PubMed ID: 2137852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.
    Am J Dig Dis; 1975 Jun; 20(6):540-71. PubMed ID: 1079402
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppression of leukocyte chemotaxis by human IgA myeloma components.
    Van Epps DE; Williams RC
    J Exp Med; 1976 Nov; 144(5):1227-42. PubMed ID: 825608
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human eosinophil chemotaxis by IgA paraproteins.
    Reed KJ; Van Epps DE; Williams RC
    Inflammation; 1979 Sep; 3(4):405-16. PubMed ID: 116966
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.
    Murgita RA; Tomasi TB
    J Exp Med; 1975 Feb; 141(2):269-86. PubMed ID: 46267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.